European Archives - Page 97 of 995 - European Medical Journal

ESC President 2024 Interview: Thomas Lüscher

We are a global society, we have 58 national cardiac societies and 47 affiliated cardiac societies. At our recent Annual Congress in London at the end of August, we had participants from over 80 countries.

Upper GI Damage Linked to 76% Higher Parkinson’s Risk

Individuals with upper gastrointestinal mucosal damage may be at an increased risk of developing Parkinson’s disease later in life.

Racial Differences in Breast Cancer Survival Across all Tumour Types

Researchers have identified that Black women in the United States have significantly higher breast cancer mortality rates than White women

Bonus Episode: c-Met Protein Overexpression as an Emerging Biomarker in NSCLC

A bonus podcast episode, featuring an expert discussion on c-Met protein overexpression as an emerging biomarker in NSCLC

The Association Between Mean Heart Rate and Sepsis Mortality

A study reveals a J-shaped link between mean heart rate and 30-day mortality in older ICU patients with sepsis. The lowest risk was observed for heart rates between 73 and 82 bpm,

Proteins in Meat and Milk Found to Suppress Gut Tumours

A new study has revealed that proteins found in foods such as meat and milk can help suppress the growth of tumours in the small intestines

COVID-19 Vaccination Landscape

COVID-19 vaccines recommended by the Centers for Disease Control and Prevention (CDC): two mRNA vaccines and a protein-based vaccine…

EMJ Microbiology and Infectious Diseases 5 [Supplement 2] 2024

In the USA, there are currently three licensed COVID-19 vaccines recommended by the Centers for Disease Control and Prevention (CDC): two…

Handshake on blue background

Novo Nordisk expands stem cell research arm with Evotec

Evotec has joined forces with Novo Nordisk to advance the clinical and commercial manufacturing of stem cell-based therapies.

Tumour-Specific Antibodies Detect Early Melanoma: EADV 2024

A new method for early melanoma detection, using tumour-specific antibody profiling, was presented at the EADV Congress 2024.